Renaissance Capital logo

IKNA News

US IPO Weekly Recap: Healthcare shines in a 17 IPO week

DRS

In a turbulent week for the IPO market, 17 IPOs and 20 SPACs went public, and one company postponed, defense contractor Leonardo DRS (DRS). While returns cooled off, with just over half of the week’s IPOs finishing below issue, there...read more

Oncology biotech Ikena Oncology prices IPO at $16 midpoint

Ikena Oncology logo

Ikena Oncology, a Phase 1 oncology biotech developing small molecule inhibitor therapies, raised $125 million by offering 7.8 million shares at $16, within the range of $15 to $17. Ikena Oncology is a targeted oncology company focused on developing novel...read more

Oncology biotech Ikena Oncology sets terms for $125 million IPO

Ikena Oncology logo

Ikena Oncology, a Phase 1 oncology biotech developing small molecule inhibitor therapies, announced terms for its IPO on Monday. The Boston, MA-based company plans to raise $125 million by offering 7.8 million shares at a price range of $15 to $17. At the...read more

US IPO Week Ahead: Cleaning products, crafting machines, and more in a diverse 15 IPO week

DSEY

Updated Monday, 3/22. 15 IPOs are currently scheduled to raise $5.7 billion in the week ahead as IPO activity continues to pick up. The diverse group spans six sectors and includes cleaning products, defense technology, low-cost TVs, crafting...read more